Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).
Part I of this article, which appeared in the previous issue of the Journal, discussed the implications of variations in plasma protein levels in a number of diseases: hepatic and renal disease, acute myocardial infarction, burns, cancer, diabetes mellitus, hyperlipidaemia and inflammatory diseases. In Part II the authors continue their review with a further range of disease states, and consider their import for drug dosages.
Department Hospital-Universitaire de Pharmacologie, Créteil, France.
R
R
Zini
P
P
Riant
J
J
Barré
J P
JP
Tillement
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D006801:Humans; D009748:Nutrition Disorders / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010599:Pharmacokinetics; D013959:Thyroid Diseases / Q000378:metabolism
D001798:Blood Proteins; D004364:Pharmaceutical Preparations